On Behalf of the NBHPI, NOF Submits Comment Letters
Fail first is not an option when bones are at risk of breaking.
NOF on behalf of the NBHPI has submitted comments to CMS and HHS regarding proposed rules that could impact osteoporosis patients access to testing and treatment. Comment letters have been submitted on the following topics:
December 31, 2019 - Advance Notice of Proposed Rulemaking: International Price Index Model for Medicare Part B Drugs CMS-5528-ANPRM
January 25, 2019 - Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out of Pocket Expenses, CMS-4180-P
April 3, 2019 - Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees
NOF has started to engage in the protection of care for osteoporosis patients by commenting on rules and regulations that could, if passed, impact the health of our community. We are interested in rules and regulations that could impact the cost of medicines, the ability of doctors to prescribe the medicines they believe are right for patients without moving through a concept called “fail first”, and, overall insurance protections for our patient community. This isn’t engaging in “politics”; it is the truest form of advocacy. At NOF we’re not concerned about political affiliations or party alignment. We are concerned that the policies and regulations support healthcare programs and services that will protect our patient community and their bone health. What are we focused on?
Adequate, affordable, and available health insurance coverage is critical for individuals with osteoporosis. NOF calls on policymakers to support public policies that:
1. Provide osteoporosis patients with access to affordable, comprehensive health care;
2. Stabilize the individual and small group markets; and
3. Protect patients from discrimination against pre-existing conditions.